Clinical Trials

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT07602010 2026-05-22

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

150 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07589413 2026-05-15

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

150 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms, Recurrence, Disease Progression

NCT04146064 2026-05-08

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

DermatologicGenitourinaryHead & Neck

190 enrolled

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

NCT07525349 2026-04-13

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

100 enrolled

Tertiary Lymphoid Structures, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04970472 2026-03-19

MicroBlad

1,000 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT07454941 2026-03-06

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Enrolling by invitation

4,000 enrolled

Carcinoma, Transitional Cell, Disease

NCT07452432 2026-03-05

Korean Prospective Upper Tract Urothelial Carcinoma Cohort

300 enrolled

Carcinoma, Transitional Cell

NCT07441499 2026-03-02

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

300 enrolled

Carcinoma, Transitional Cell, Neoplasms

NCT06657157 2026-02-24

P-EVOLUTION

80 enrolled

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT06138561 2026-02-17

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

180 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06724159 2026-02-17

SOGUG-PRINCIS

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT07395037 2026-02-09

WASHOUT

1,050 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms, Urologic Diseases

NCT07390617 2026-02-05

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT07339878 2026-01-14

FLORAL

Carcinoma, Transitional Cell

NCT07334314 2026-01-12

OUAF

340 enrolled

Carcinoma, Transitional Cell

NCT06120374 2025-12-30

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

178 enrolled

Carcinoma, Transitional Cell

NCT06339138 2025-12-24

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Active not recruiting

589 enrolled

Oncocytoma, renal, Carcinoma, Renal Cell, Carcinoma, Transitional Cell

NCT06129084 2025-12-15

A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing

Active not recruiting

260 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04566029 2025-12-10

AMI

40 enrolled

Carcinoma, Transitional Cell

NCT06396533 2025-10-31

INSITE

92 enrolled

Carcinoma, Transitional Cell

NCT06310759 2025-10-10

UROSCOUT-1

3,000 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04892849 2025-09-17

ST-ICI02

GastrointestinalGenitourinaryHead & Neck

200 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms

NCT07091565 2025-08-03

SPARC

Enrolling by invitation

60 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT07072637 2025-07-18

Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy

100 enrolled

Carcinoma, Transitional Cell

NCT06982794 2025-05-21

Urolife

Carcinoma, Transitional Cell

NCT05290038 2025-04-02

ARON-2 Study-Multicentric International Retrospective Study

367 enrolled

Carcinoma, Transitional Cell

NCT06663735 2024-10-29

Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma

400 enrolled

Carcinoma, Transitional Cell

NCT06469229 2024-07-05

Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria

1,200 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Ureteral Neoplasms

NCT06427993 2024-06-20

Urine DNA Methylation Detection for Hematuria Evaluation

71 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Ureteral Neoplasms

NCT04641936 2024-04-17

Urine Omics Predicting IO Therapy Responses in mUC Patients

600 enrolled

Carcinoma, Transitional Cell

NCT06321640 2024-03-20

POSITive

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

265 enrolled

Breast Neoplasms, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT05700344 2024-02-29

SOGUG

125 enrolled

Carcinoma, Transitional Cell

NCT04994197 2024-01-10

Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS

970 enrolled

Carcinoma, Transitional Cell

NCT06193941 2024-01-09

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

400 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06169904 2023-12-14

B7-Family Score in Urothelial Carcinoma

215 enrolled

Carcinoma, Transitional Cell

NCT04535921 2023-12-11

Fear of Cancer Recurrence in Genitourinary Cancer

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Prostatic Neoplasms, Testicular Neoplasms

NCT05154084 2023-11-14

RESECT

19,505 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06116396 2023-11-07

CIRCE

450 enrolled

Carcinoma, Transitional Cell

NCT06120413 2023-11-07

18F-LN1 PET/CT in Urothelial Carcinomas

30 enrolled

Carcinoma, Transitional Cell

NCT06113367 2023-11-02

VESUVIO

350 enrolled

Carcinoma, Transitional Cell

NCT05893316 2023-06-07

UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study

1,000 enrolled

Carcinoma, Transitional Cell, Hematuria

NCT03677544 2023-05-17

CYSTECTOMEN

748 enrolled

Carcinoma, Transitional Cell

NCT05503563 2022-08-16

A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05139134 2022-07-29

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT04718948 2022-05-09

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

NCT04770974 2022-05-09

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

200 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04960956 2022-03-14

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

Terminated

13 enrolled

Carcinoma, Transitional Cell, Prostatic Neoplasms

NCT03548688 2021-11-11

IDENTIFY

11,059 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria

NCT04432909 2021-09-16

A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up